Comparison of Sepsis Prediction Algorithms

Sponsor
Emory University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05943938
Collaborator
(none)
1,200
7
6
171.4
28.4

Study Details

Study Description

Brief Summary

Sepsis is a severe response to infection resulting in organ dysfunction and often leading to death. More than 1.5 million people get sepsis every year in the U.S., and 270,000 Americans die from sepsis annually. Delays in the diagnosis of sepsis lead to increased mortality. Several clinical decision support algorithms exist for the early identification of sepsis. The research team will compare the performance of three sepsis prediction algorithms to identify the algorithm that is most accurate and clinically actionable. The algorithms will run in the background of the electronic health record (EHR) and the predictions will not be revealed to patients or clinical staff. In this current evaluation study, the algorithms will not affect any part of a patient's care. The algorithms will be deployed across the Emory healthcare system on data from all patients presenting to the emergency department.

Condition or Disease Intervention/Treatment Phase
  • Other: Epic Sepsis Model Version - 1
  • Other: Epic Sepsis Model Version - 2
  • Other: Emory Sepsis Model

Detailed Description

The primary goal of this study is to prospectively evaluate three sepsis prediction algorithms that are embedded in the EHR. The models will be deployed in a "shadow" mode, and the results will not be displayed to the treatment team during this study. Two of the algorithms are proprietary algorithms of the EHR provider (Epic). The third algorithm is an internally developed, open-source algorithm.

The algorithms will compute the probability of sepsis at periodic intervals and will continue to run on a patient's data until the patient's discharge, death, or upon initiation of intravenous antibiotics (at which point there is an indirect record of clinical suspicion of an infection).

Study Design

Study Type:
Observational
Anticipated Enrollment :
1200 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Prospective Evaluation of Sepsis Prediction Algorithms in a Multi-Hospital Healthcare System
Anticipated Study Start Date :
Jul 1, 2023
Anticipated Primary Completion Date :
Jan 1, 2024
Anticipated Study Completion Date :
Jan 1, 2024

Arms and Interventions

Arm Intervention/Treatment
ED Patients

All adult patients presenting to Emergency Departments (ED) in the Emory Healthcare system

Other: Epic Sepsis Model Version - 1
The Epic Sepsis Model (ESM) version 1, a proprietary sepsis prediction model.
Other Names:
  • Proprietary Epic sepsis algorithm -1
  • Other: Epic Sepsis Model Version - 2
    The Epic Sepsis Model (ESM) version 2, a proprietary sepsis prediction model.
    Other Names:
  • Proprietary Epic sepsis algorithm -2
  • Other: Emory Sepsis Model
    Emory internal algorithm
    Other Names:
  • Emory Sepsis Algorithm
  • Outcome Measures

    Primary Outcome Measures

    1. Patient hospitalization-level area under curve (AUC) for identification of sepsis, [Duration of hospital stay (until discharge or death), an expected average of 30 days]

      Definition of Sepsis using the Centers for Disease Control and Prevention (CDC) Adult Sepsis Surveillance.

    Secondary Outcome Measures

    1. Sensitivity, specificity, and Positive and Negative Predictive Value of algorithms [Duration of hospital stay (until discharge or death), an expected average of 30 days]

      Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV).

    2. Lead time to antibiotic administration [Duration of hospital stay (until discharge or death), an expected average of 30 days]

      The time between the initial deployment of the alert in patients confirmed to have sepsis (ture positives) and the physician's ordering of intravenous antibiotic therapy.

    3. Percent expected increase in unnecessary antibiotics [Duration of hospital stay (until discharge or death), an expected average of 30 days]

      Percent of patients who were incorrectly identified as having sepsis (false positives), and received antibiotics.

    4. Number needed to screen [Duration of hospital stay (or death), an expected average of 30 days]

      The number of alerts that would need to be processed to find one true positive sepsis.

    5. Total and false alert burden [Duration of hospital stay (until discharge or death), an expected average of 30 days]

      Total and false alert burden

    6. Time-horizon based AUCs [4 hours, 8 hours, and 24 hours]

      AUCs will be calculated at 3 pre-specified time horizons.

    7. Accuracy and calibration by subgroup [Duration of hospital stay (until discharge or death), an expected average of 30 days]

      The AUC and calibration curves will be compared by sex and race to ensure predictive accuracy is equal across subgroups.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • All adult patients admitted through the ED
    Exclusion Criteria:
    • None

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Emory Midtown Hospital Atlanta Georgia United States 30308
    2 Emory Saint Joseph's Hospital Atlanta Georgia United States 30308
    3 Emory Healthcare System Atlanta Georgia United States 30322
    4 Emory Hospital Atlanta Georgia United States 30322
    5 Emory Decatur Hospital Decatur Georgia United States 30033
    6 Emory Johns Creek Hospital Johns Creek Georgia United States 30097
    7 Emory Hillandale Hospital Lithonia Georgia United States 30058

    Sponsors and Collaborators

    • Emory University

    Investigators

    • Principal Investigator: Sivasubramanium Bhavani, MD, Emory University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Siva Bhavani, Assistant Professor, Emory University
    ClinicalTrials.gov Identifier:
    NCT05943938
    Other Study ID Numbers:
    • STUDY00005958
    First Posted:
    Jul 13, 2023
    Last Update Posted:
    Jul 13, 2023
    Last Verified:
    Jul 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Siva Bhavani, Assistant Professor, Emory University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 13, 2023